title: Safety of voriconazole and dose individualization.
authors.forename: Irja
authors.initials: I
authors.lastname: Lutsar
authors.forename: Mike R
authors.initials: MR
authors.lastname: Hodges
authors.forename: Konrad
authors.initials: K
authors.lastname: Tomaszewski
authors.forename: Peter F
authors.initials: PF
authors.lastname: Troke
authors.forename: Nolan D
authors.initials: ND
authors.lastname: Wood
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D016867:Immunocompromised Host; D008111:Liver Function Tests; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D014230:Triazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D065819:Voriconazole
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole